SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

HRTX

Heron Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.36 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,3858 flagged findings
Reported transactions (Form 4)80since Jan 19, 2026 · and 17 other holdings
Corporate events (8-K)30since Aug 10, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jun 25, 2026).

Deadline: Dec 22, 2026

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Jun 25, 2026 · pending · deadline Dec 22, 2026 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,385)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 29, 268-K ↗Current report · Entered a material agreement
  • Aug 14, 268-K ↗Current report · Entered a material agreement
  • Aug 10, 26Form 4 ↗Insider transaction
  • Aug 10, 2610-Q ↗Quarterly report
  • Aug 10, 268-K ↗Current report · Results
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 25, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jun 17, 26Form 4 ↗Insider transaction
  • Jun 16, 268-K ↗Current report · Shareholder vote results
  • Jun 8, 26Form 4 ↗Insider transaction
  • Jun 2, 268-K ↗Current report · Other events
  • May 13, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 11, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Insider transaction · 5 Form 4 filingsshow all 5hide

1,385 filings on record, the oldest from Feb 1, 94.

Listing the 25 most recent filings of the 1,385 on record.

8-Ks, explained

Stress17Structure63Governance60
  • Sep 29, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Aug 14, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 25, 26StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Apr 6, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Oct 29, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure5 material agreements entered2025show all 5hide
    • Aug 28, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Aug 15, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Aug 12, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Aug 12, 25StructureEntered a material agreement8-K 1.01 ↗
    • Aug 8, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Apr 29, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 20, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024show all 3hide
    • Nov 4, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 18, 24GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Mar 21, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 11, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Dec 21, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 24, 23StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗

6 older filings not shown · The record reaches back to Sep 21, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Jun 30, 22StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
  • Jul 17, 19StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jan 29, 16StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 2, 11StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 4, 11StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Feb 9, 11StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Nov 22, 10StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • May 20, 10StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Nov 24, 09StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

The full record holds 17 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Rubric Capital Management LP15.9%Oct 15, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Clearline Capital LP6.7%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • The Vanguard Group5.3%Dec 31, 25SCHEDULE 13G ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 40 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 6, 26Compensationamount n/aMark Earl HensleyChief Operating Officer↗
  • Aug 6, 26Tax$4KMark Earl HensleyChief Operating Officer↗
  • Jul 31, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Jul 31, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Jul 31, 26Tax$2KIra DuarteEVP, Chief Financial Officer↗
  • Jul 31, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Jul 31, 26Tax$2KWilliam P ForbesEVP, Chief Development Officer↗
  • Jul 31, 26Compensationamount n/aMark Earl HensleyChief Operating Officer↗
  • Jul 30, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Jul 30, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Jul 30, 26Tax$2KIra DuarteEVP, Chief Financial Officer↗
  • Jul 30, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Jul 30, 26Tax$2KWilliam P ForbesEVP, Chief Development Officer↗
  • Jul 19, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Jul 19, 26Tax$517Ira DuarteEVP, Chief Financial Officer↗
  • Jul 19, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Jul 19, 26Tax$517William P ForbesEVP, Chief Development Officer↗
  • Jul 19, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Jun 16, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Jun 16, 26Tax$1KIra DuarteEVP, Chief Financial Officer↗
  • Jun 6, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • May 6, 26Compensationamount n/aMark Earl HensleyChief Operating Officer↗
  • Apr 30, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Apr 30, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Apr 30, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Apr 30, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Apr 30, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Apr 30, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Apr 30, 26Compensationamount n/aMark Earl HensleyChief Operating Officer↗
  • Apr 19, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Apr 19, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Apr 19, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Apr 3, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Jan 31, 26Compensationamount n/aCraig A CollardChief Executive Officer↗
  • Jan 31, 26Compensationamount n/aWilliam P ForbesEVP, Chief Development Officer↗
  • Jan 31, 26Compensationamount n/aIra DuarteEVP, Chief Financial Officer↗
  • Jan 30, 26Compensationamount n/aAdam Morgan↗
  • Jan 30, 26Compensationamount n/aSharmila Dissanaike↗
  • Jan 30, 26Compensationamount n/aThomas Cusack↗
  • Jan 30, 26Compensationamount n/aCraig A Johnson↗

The full record holds 156 transactions and goes back to Oct 31, 22.

Its sector and its market

Heron Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Heron Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Heron Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
1,385 documents on file, from Feb 1, 1994 to Sep 29, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Heron Therapeutics Inc. (HRTX): stock price history, insider trades and SEC filings — HornScout